Technology And Equipment Tenders

Openhouse Procedure Dressing Materials

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Medicines with the Active Ingredient Combination Vilanterol, Umeclidinium Bromide and Fluticasone Furoate (Atc: R03al08)

Medicines with the Active Ingredient Combination Formoterol, Glycopyrronium Bromide and Beclometasone (Atc: R03al09)

Medicines with the Active Ingredient Fampridine (Atc: N07xx07)

Medicines with the Active Ingredient Dupilumab (Atc: D11ah05)

Medicines with the Active Ingredient Tiotropium Bromide (Atc: R03bb04 - Except in the Dosage Form Hard Capsules with Powder for Inhalation)

Delivery of Rail Chamber Elements for Rail Shapes Ri 53-10, 49E1, 60R1, 60R2, 55R1, 59R1 and 59R2 as Well as Rail Foot Pads Made from Recyclable Materials

Open House Drug Discount Agreements Calcipotriol and Betamethasone, Excluding Ointments, Atc D05ax22

Open House Drug Discount Agreements Lamivudine, Tenofovir Disoproxil and Doravirine, Atc J05ar24